Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
Clinical trial NCT04925934 · COMPLETED
Trial details
- NCT number
- NCT04925934
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2023-05-16
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.